Randomized open-label phase III multicenter trial comparing TAXOL®/doxorubicin (AT) versus 5-fluorouracil/doxorubicin and cyclophosphamide (FAC) as a first line treatment for patients with metastatic breast cancer
Płuż;zańska, A., Jassem, J., Jelič, S., Gorbunova, V., Mrsič-Krmpotič, Z., Berzins, J., Nagykálnai, T., Wigler, N., Renard, J., Statuch, C.
Published in European journal of cancer (1990) (01.09.1999)
Published in European journal of cancer (1990) (01.09.1999)
Get full text
Journal Article